Human Fas Ligand/TNFSF6 Standard (人Fas配体 标准品)
¥280.00
因产品会迭代升级,具体实验步骤请按纸质版说明书操作
描述
文章目录[隐藏]
本产品只包含标准品试剂,如需购买试剂盒请点击下图
-
- EK1F02
- ELISA试剂盒
Human Fas Ligand/TNFSF6 ELISA Kit检测试剂盒(酶联免疫吸附法)
- ¥1,600.00 – ¥2,650.00
商品名 |
Human Fas Ligand/TNFSF6 Standard (人Fas配体 标准品) |
---|---|
组分 |
人Fas Ligand标准品 |
检测方法 |
双抗夹心法 |
样本类型 |
血清,血浆,细胞培养上清及其他生物学样本 |
板式 |
管 |
保存 |
短期4℃,长期-20℃保存 |
运输条件 |
4℃蓝冰运输 |
检测原理:本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性抗人Fas Ligand抗体预包被在高亲和力的酶标板上。酶标板孔中加入标准品、待测样本和生物素化的检测抗体,经过孵育,样本中存在的Fas Ligand与固相抗体和检测抗体结合。洗涤去除未结合的物质后,加入辣根过氧化物酶标记的链霉亲和素(Streptavidin-HRP)。洗涤后,加入显色底物TMB,避光显色。颜色反应的深浅与样本中Fas Ligand的浓度成正比。加入终止液终止反应,在450 nm波长(参考波长570 - 630 nm)测定吸光度值。
分子信息
FASLG 分子靶点信息概述
- 分子名:FASLG, Fas ligand
- 基因家族:CD molecules; Tumor necrosis factor superfamily; Death inducing signaling complex
- 别名:FasL; CD178
- 曾用名:APT1LG1; TNFSF6
- 全称:tumor necrosis factor (ligand) superfamily, member 6; Fas ligand (TNF superfamily, member 6)
FASLG 分子靶点综述
Fas配体,又名TNFSF6、FasL或CD95L,是肿瘤坏死因子(TNF)家族中的一员。它是一个在细胞毒性T淋巴细胞上表达的同源三聚体II型跨膜蛋白。外基质金属蛋白酶MMP-7在保守裂解位点裂解膜结合的FasL可生成可溶性Fas配体。Fas配体/受体的相互作用在调节免疫系统和癌症的进展中发挥重要作用。它通过FasR的三聚体化产生信号,这个三聚体化通常会导致细胞凋亡或死亡。由Fas-Fas配体结合所引起的凋亡在免疫系统的调节中发挥至关重要的作用,它的功能包括T细胞稳态、细胞毒性T细胞活性、免疫特权、母体耐受性和肿瘤反击。有缺陷的Fas介导的细胞凋亡可导致肿瘤的发生和现有肿瘤的耐药性。Fas基因突变与自身免疫性淋巴增生综合征(ALPS)相关。
人 Human FASLG 分子靶点信息
- 分子名:FASLG, Fas ligand
- 别称:
- ALPS1B
- apoptosis (APO-1) antigen ligand 1
- apoptosis antigen ligand
- APT1LG1
- APTL
- CD178
- CD95 ligand
- CD95-L
- CD95L
- fas antigen ligand
- Fas ligand (TNF superfamily, member 6)
- FASL
- mutant tumor necrosis factor family member 6
- TNFSF6
- TNLG1A
- tumor necrosis factor (ligand) superfamily, member 6
- tumor necrosis factor ligand 1A
- tumor necrosis factor ligand superfamily member 6
- 基因序列:NCBI_Gene: 356
- 蛋白序列:UniProtKB: P48023
人 Human FASLG靶点分子功能(预测)
Predicted to enable signaling receptor binding activity. Involved in several processes, including necroptotic signaling pathway; positive regulation of endothelial cell apoptotic process; and positive regulation of phosphatidylserine exposure on apoptotic cell surface. Acts upstream of or within extrinsic apoptotic signaling pathway via death domain receptors; positive regulation of apoptotic process; and release of sequestered calcium ion into cytosol by endoplasmic reticulum. Located in extracellular exosome; nucleus; and plasma membrane. Implicated in several diseases, including cholangiocarcinoma; chronic myeloid leukemia; pancreatic cancer (multiple); pre-eclampsia (multiple); and type 2 diabetes mellitus. Biomarker of several diseases, including bone marrow cancer (multiple); carcinoma (multiple); cervix uteri carcinoma in situ; clonorchiasis; and neurodegenerative disease (multiple).
操作步骤
文章目录[隐藏]
- ELISA操作常见问题
- 血清OR血浆,哪个是ELISA的菜 
- ELISA通关必备丨数据篇丨标准曲线不佳 
- ELISA通关必备丨操作篇丨常见问题及解决方案 
- ELISA通关必备丨操作篇丨溶解与稀释标准品 
- ELISA通关必备丨样本篇丨不常见样本 
- ELISA通关必备丨样本篇丨常见样本丨细胞 
- ELISA通关必备丨如何选择试剂盒 
- ELISA通关必备丨基础知识 
- 真?假?ELISA试剂盒选择要小心 
- ELISA常见类型一 | 双抗夹心法,你要的都在这里! 
- ELISA常见类型二 | 竞争法,五分钟搞定! 
- 叮!联科向您投递了个ELISA实验操作干货包,请查收~ 
- 【视频】ELISA实验操作步骤演示视频教程 
- ELISA 组织样本的处理—大鼠组织 
- 【视频】ELISA实验原理与常见问题分析 
- 查看更多ELISA操作相关问题
ELISA操作常见问题
查看更多ELISA操作相关问题
引用文献
文章目录[隐藏]
- Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy 
- Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy 
Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy 
- 细胞培养上清
Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy 
评价
目前还没有评价